Ourania Tatsis, EVP, Chief Reg. & Quality Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 1,887 shares at $486.35 ($916K) on 2026-02-25, disclosed to the SEC on 2026-02-26.
Scheduled sale ($916k) by EVP, Chief Reg. & Quality Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $485.11 | 1,627 | $789K | 86.2% |
| 2 | $486.35 | 260 | $126K | 13.8% |
| Total | $485.28 avg | 1,887 | $916K | 100% |
| Filing → |
| VRTX | SELL | 2026-02-18 | $750K | — | Filing → |
| VRTX | SELL | 2026-02-12 | $215K | — | Filing → |
| VRTX | SELL | 2026-01-09 | $2.1M | — | Filing → |